Clinical Trials EISNER Study 1

Protocol Title:

Early Identification of Subclinical Atherosclerosis using NoninvasivE Imaging Research (EISNER) Study 1.

Working Title:

The purpose of this study is to determine if a particular combination of assessments can predict future clinical outcomes in patients who have had no symptoms of coronary artery disease or other heart disease. The combination of assessments in this study includes medical history and risk factor information, a clinical exam, biochemical tests performed on a blood sample, and a cardiac CT imaging procedure.

Enrollment is closed.

Principal Investigator:

Daniel S. Berman, MD

IRB Approval Number:

3351

Medical Specialty Area:

Cardiac Imaging- CT

Condition/Disease:

Coronary Heart Disease

IRB Approval Expiration Date:

07/31/2011

Contact Information for patients wishing more information:

Name: Johanna Kim
Phone: (310) 423-4327
E-mail: KimJHM@cshs.org print button
WP3